Citation: Co. Onyeji et Fa. Ogunbona, Pharmacokinetic aspects of chloroquine-induced pruritus: influence of doseand evidence for varied extent of metabolism of the drug, EUR J PH SC, 13(2), 2001, pp. 195-201
Authors:
Nicolau, DP
Onyeji, CO
Banevicius, MA
Li, J
Nightingale, CH
Citation: Dp. Nicolau et al., Effects of adjunctive treatment with combined cytokines in a neutropenic mouse model of multidrug-resistant Enterococcus faecalis septicemia, PHARMACOTHE, 21(3), 2001, pp. 275-280
Authors:
Onyeji, CO
Nicolau, DP
Nightingale, CH
Bow, L
Citation: Co. Onyeji et al., Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection, J ANTIMICRO, 46(3), 2000, pp. 429-436
Authors:
Nicolau, DP
Onyeji, CO
Zhong, MK
Tessier, PR
Banevicius, MA
Nightingale, CH
Citation: Dp. Nicolau et al., Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: Implications for breakpoint determinations, ANTIM AG CH, 44(5), 2000, pp. 1291-1295
Authors:
Onyeji, CO
Bui, KQ
Nicolau, DP
Nightingale, CH
Bow, L
Quintiliani, R
Citation: Co. Onyeji et al., Influence of adjunctive interferon-gamma on treatment of gentamicin- and vancomycin-resistant Enterococcus faecalis infection in mice, INT J ANT A, 12(4), 1999, pp. 301-309
Authors:
Onyeji, CO
Bui, KQ
Owens, RC
Nicolau, DP
Quintiliani, R
Nightingale, CH
Citation: Co. Onyeji et al., Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia, INT J ANT A, 12(2), 1999, pp. 107-114
Authors:
Onyeji, CO
Nicolau, DP
Nightingale, CH
Bow, L
Citation: Co. Onyeji et al., Interferon-gamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils, INT J ANT A, 11(1), 1999, pp. 31-37
Authors:
Tessier, PR
Nicolau, DP
Onyeji, CO
Nightingale, CH
Citation: Pr. Tessier et al., Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosain an in vitro infection model, CHEMOTHERA, 45(4), 1999, pp. 284-295